factors between the intervention groups compared with the control group. There were no increases in total- or
LDL cholesterol in the cheese groups compared with the control. Stratified analysis showed that those in the
Gouda group with metabolic syndrome at baseline had significant reductions in total cholesterol at the end
of the trial compared with control (0.70 mmol/L, p0.013), and a significantly higher reduction in mean
triglycerides. In the Gamalost group, those who had high total cholesterol at baseline had a significant
reduction in total cholesterol compared with control (0.40 mmol/L, p0.035).